Loading company…
Riskpilot
← Back to search
Sign in
Get full access
OT Pharmaceuticals AB
AB
Active
Org 5569195463
Kanalvägen 61
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2013
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 4,1M
+31% vs 2024
EBITDA margin
28.8%
+154% vs 2024
Equity ratio
83.4%
Financial strength
Net profit 2025
SEK 974K
+199% vs 2024
EBITDA — year on year
SEK millions
1M
1M
1M
0M
0M
1M
2021
1M
0%
2022
0M
-100%
2023
0M
0%
2024
1M
+100%
2025
Key figures
Annual report 2025
Revenue
SEK 4,1M
+31%
EBITDA
SEK 1,2M
+154%
Net profit
SEK 974K
+199%
Total assets
SEK 2,6M
+38%
Equity
SEK 2,1M
+84%
Employees
1
—
Company information
Legal name
OT Pharmaceuticals AB
Org number
5569195463
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
18 januari 2013
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva läkemedelsforskning och utveckling och därmed förenlig verksamhet.
Contact
Address
Kanalvägen 61
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Uppsala
All Sweden companies
Revenue
SEK millions
0M
1M
2M
3M
5M
2M
2021
1M
2022
1M
2023
3M
2024
4M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2021
1M
2022
0M
2023
0M
2024
1M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
1 588
1 481
1 015
3 136
4 096
Staff expenses
—
−326
−350
−1 649
−2 048
EBITDA
1 238
1 068
302
464
1 179
Depreciation & amort.
−65
−65
−49
—
—
EBIT
1 173
1 003
253
464
1 179
Net financials
−110
−65
−452
−37
48
Profit before tax
1 162
738
1
426
1 227
Tax
−265
−168
−100
−100
−253
Net profit
897
570
−99
326
974
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
1 729
1 298
1 575
1 861
2 565
Equity
1 147
937
838
1 164
2 138
Long-term debt
0
—
—
—
—
Short-term debt
582
161
736
696
426
Total debt
582
161
736
696
426
Financial ratios
5-year trend
EBITDA margin
28.8%
This company
15.8%
Market median
+82% vs market
2021
2025
Equity ratio
83.4%
This company
38.2%
Market median
+118% vs market
2021
2025
Return on equity
45.5%
This company
18.4%
Market median
+147% vs market
2021
2025
Net profit margin
23.8%
This company
8.1%
Market median
+194% vs market
2021
2025
Asset turnover
1.60×
This company
1.12×
Market median
+43% vs market
2021
2025
Debt / equity
0.20×
This company
0.62×
Market median
+68% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
PF
Per Fredrik Lehmann
Chief Executive Officer
Chief Executive Officer
2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
WE
William Emil Fredrik Lehmann
Deputy Board Member
2022
Former (1)
PF
Peter Friedrich Wilhelm Lehmann
Deputy Board Member
2022 – 2023
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
OT Pharmaceuticals AB
(this company)
Gulch Pharma AB
Board network connections
Board members of OT Pharmaceuticals AB also hold positions in
0
other companies.
Person
Role here
Other companies
Per Fredrik Lehmann
Chief Executive Officer
0 companies
William Emil Fredrik Lehmann
Deputy Board Member
0 companies
Peter Friedrich Wilhelm Lehmann
Deputy Board Member
0 companies